| GlaxoSmithKline AG - Volibris 5 mg, Filmtabletten | | 58654 | | 01 | | Volibris 5 mg | | Filmtabletten | | C02KX02 | | Ambrisentan | | 05.11.2008 | | |
| | Composition | | ambrisentanum 5 mg, lactosum monohydricum 95 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.35 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, lecithinum ex soja, E 171, E 129 0.105 mg, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Ambrisentanum | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Ambrisentanum | 5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 129 | 0.105 mg | color. | | E 171 | | color. | | Lactose Monohydrate | 95 mg | | | Lecithinum ex Soja | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 Tablet(s) | 1089.60 | 1195.35 | B | SL | No |
|
|
